Cargando…

A Short Knowledge Assessment Tool Is Valid and Acceptable for Adults with Inflammatory Bowel Disease

BACKGROUND: For people with inflammatory bowel disease, validated knowledge questionnaires are valuable to identify gaps in understanding and explore the impact on disease variables. AIMS: The aim of this study was to validate the short knowledge questionnaire Inflammatory Bowel Disease Knowledge In...

Descripción completa

Detalles Bibliográficos
Autores principales: Buerkle, Katrin S., Vernon-Roberts, Angharad, Ho, Christine, Schultz, Michael, Day, Andrew S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9068503/
https://www.ncbi.nlm.nih.gov/pubmed/35511411
http://dx.doi.org/10.1007/s10620-022-07507-7
_version_ 1784700233353003008
author Buerkle, Katrin S.
Vernon-Roberts, Angharad
Ho, Christine
Schultz, Michael
Day, Andrew S.
author_facet Buerkle, Katrin S.
Vernon-Roberts, Angharad
Ho, Christine
Schultz, Michael
Day, Andrew S.
author_sort Buerkle, Katrin S.
collection PubMed
description BACKGROUND: For people with inflammatory bowel disease, validated knowledge questionnaires are valuable to identify gaps in understanding and explore the impact on disease variables. AIMS: The aim of this study was to validate the short knowledge questionnaire Inflammatory Bowel Disease Knowledge Inventory Device 2, known as IBD-KID2, for use with adults with inflammatory bowel disease. METHODS: Concurrent validity of IBD-KID2 was assessed by comparing scores with those achieved on the Crohn’s and Colitis Knowledge Score (CCKNOW). IBD-KID2 reliability was assessed with test–retest completion at two time points, generalizability assessed by comparing IBD-KID2 cohort scores at different recruitment centres, and acceptability assessed using participant survey. RESULTS: Seventy-five adults with inflammatory bowel disease completed the study. The mean percentage scores achieved on the IBD-KID2 and CCKNOW were 72.8% (SD 16.0) and 49.7% (SD 18.2), respectively. There was a significant correlation between IBD-KID2 and CCKNOW scores (R 0.573, P < 0.005), confirming concurrent validity. IBD-KID2 reliability was confirmed as no significant difference was seen between scores at test and retest (mean difference −0.2, P = 0.92). Generalizability was established as no significant score difference was seen between recruitment centres after controlling for population differences. The acceptability survey showed that 49 (69%) participants preferred IBD-KID2 to the CCKNOW, 60 (85%) found the IBD-KID2 easier to complete, and 38 (53%) considered the CCKNOW as most suitable for adults. CONCLUSIONS: IBD-KID2 is a valid, reliable, and generalizable tool for measuring knowledge in adults with inflammatory bowel disease with good acceptability. IBD-KID2 is easy and quick to complete, hence limiting respondent burden. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s10620-022-07507-7.
format Online
Article
Text
id pubmed-9068503
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-90685032022-05-04 A Short Knowledge Assessment Tool Is Valid and Acceptable for Adults with Inflammatory Bowel Disease Buerkle, Katrin S. Vernon-Roberts, Angharad Ho, Christine Schultz, Michael Day, Andrew S. Dig Dis Sci Original Article BACKGROUND: For people with inflammatory bowel disease, validated knowledge questionnaires are valuable to identify gaps in understanding and explore the impact on disease variables. AIMS: The aim of this study was to validate the short knowledge questionnaire Inflammatory Bowel Disease Knowledge Inventory Device 2, known as IBD-KID2, for use with adults with inflammatory bowel disease. METHODS: Concurrent validity of IBD-KID2 was assessed by comparing scores with those achieved on the Crohn’s and Colitis Knowledge Score (CCKNOW). IBD-KID2 reliability was assessed with test–retest completion at two time points, generalizability assessed by comparing IBD-KID2 cohort scores at different recruitment centres, and acceptability assessed using participant survey. RESULTS: Seventy-five adults with inflammatory bowel disease completed the study. The mean percentage scores achieved on the IBD-KID2 and CCKNOW were 72.8% (SD 16.0) and 49.7% (SD 18.2), respectively. There was a significant correlation between IBD-KID2 and CCKNOW scores (R 0.573, P < 0.005), confirming concurrent validity. IBD-KID2 reliability was confirmed as no significant difference was seen between scores at test and retest (mean difference −0.2, P = 0.92). Generalizability was established as no significant score difference was seen between recruitment centres after controlling for population differences. The acceptability survey showed that 49 (69%) participants preferred IBD-KID2 to the CCKNOW, 60 (85%) found the IBD-KID2 easier to complete, and 38 (53%) considered the CCKNOW as most suitable for adults. CONCLUSIONS: IBD-KID2 is a valid, reliable, and generalizable tool for measuring knowledge in adults with inflammatory bowel disease with good acceptability. IBD-KID2 is easy and quick to complete, hence limiting respondent burden. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s10620-022-07507-7. Springer US 2022-05-05 2022 /pmc/articles/PMC9068503/ /pubmed/35511411 http://dx.doi.org/10.1007/s10620-022-07507-7 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by-nc/4.0/Open AccessThis article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Original Article
Buerkle, Katrin S.
Vernon-Roberts, Angharad
Ho, Christine
Schultz, Michael
Day, Andrew S.
A Short Knowledge Assessment Tool Is Valid and Acceptable for Adults with Inflammatory Bowel Disease
title A Short Knowledge Assessment Tool Is Valid and Acceptable for Adults with Inflammatory Bowel Disease
title_full A Short Knowledge Assessment Tool Is Valid and Acceptable for Adults with Inflammatory Bowel Disease
title_fullStr A Short Knowledge Assessment Tool Is Valid and Acceptable for Adults with Inflammatory Bowel Disease
title_full_unstemmed A Short Knowledge Assessment Tool Is Valid and Acceptable for Adults with Inflammatory Bowel Disease
title_short A Short Knowledge Assessment Tool Is Valid and Acceptable for Adults with Inflammatory Bowel Disease
title_sort short knowledge assessment tool is valid and acceptable for adults with inflammatory bowel disease
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9068503/
https://www.ncbi.nlm.nih.gov/pubmed/35511411
http://dx.doi.org/10.1007/s10620-022-07507-7
work_keys_str_mv AT buerklekatrins ashortknowledgeassessmenttoolisvalidandacceptableforadultswithinflammatoryboweldisease
AT vernonrobertsangharad ashortknowledgeassessmenttoolisvalidandacceptableforadultswithinflammatoryboweldisease
AT hochristine ashortknowledgeassessmenttoolisvalidandacceptableforadultswithinflammatoryboweldisease
AT schultzmichael ashortknowledgeassessmenttoolisvalidandacceptableforadultswithinflammatoryboweldisease
AT dayandrews ashortknowledgeassessmenttoolisvalidandacceptableforadultswithinflammatoryboweldisease
AT buerklekatrins shortknowledgeassessmenttoolisvalidandacceptableforadultswithinflammatoryboweldisease
AT vernonrobertsangharad shortknowledgeassessmenttoolisvalidandacceptableforadultswithinflammatoryboweldisease
AT hochristine shortknowledgeassessmenttoolisvalidandacceptableforadultswithinflammatoryboweldisease
AT schultzmichael shortknowledgeassessmenttoolisvalidandacceptableforadultswithinflammatoryboweldisease
AT dayandrews shortknowledgeassessmenttoolisvalidandacceptableforadultswithinflammatoryboweldisease